Domov › Hemofilija B › Michigan
Klinične študije za Hemofilija B v Michigan
6 študij za Hemofilija B išče udeležence na lokacijah v Michigan.
Mesta v Michigan
Uradno besedilo študije (angleško)
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- University of Michigan Medical Center, Ann Arbor
Vključevanje udeležencevFaza 3
138 Months – 206 Months · Moški · Posodobljeno 16. sep. 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- University of Michigan, Ann Arbor
Vključevanje udeležencevFaza 1/2
Starost 2 in več · Moški · Posodobljeno 11. sep. 2026 · NCT06379789Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- University of Michigan, Ann Arbor
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06003387ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–60 · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT06349473SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- MSU Center for Bleeding and Clotting Disorders, Lansing
Vključevanje udeležencevFaza 4
Starost 12–100 · Vsi spoli · Posodobljeno 12. jan. 2026 · NCT04647227Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.